The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Is Modified by SUMO in a DNA-Dependent Manner

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sinigalia, Elisa ^a   Alvisi, Gualtiero ^a,b,c   Segré, Chiara V ^d   Mercorelli, Beatrice ^a   Muratore, Giulia ^a   Winkler, Michael ^e   Hsiao, He Hsuan ^f   Urlaub, Henning ^f,g   Ripalti, Alessandro ^h   Chiocca, Susanna ^d   Palù, Giorgio ^a   Loregian, Arianna ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e Leibniz Institut für Primatenforschung   (Germany)

^f MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; PROTEIN UBC9; PROTEIN UL44; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; IN VIVO STUDY; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SUMOYLATION; VIRUS GENOME; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CYTOMEGALOVIRUS; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 84869219917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049630     Document Type: Article

References (74)

1. Moldovan GL, Pfander B, Jentsch S, (2007) PCNA, the maestro of the replication fork. Cell 129: 665-679.
2. Krishna TS, Kong XP, Gary S, Burgers PM, Kuriyan J, (1994) Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 79: 1233-1243.
3. Maga G, Hubscher U, (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116: 3051-3060.
4. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S, (2002) RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419: 135-141.
5. Naryzhny SN, Lee H, (2004) The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function. J Biol Chem 279: 20194-20199.
6. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, et al. (2006) Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8: 1359-1368.
7. Loregian A, Sinigalia E, Mercorelli B, Palu G, Coen DM, (2007) Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism. Nucleic Acids Res 35: 4779-4791.
8. Komazin-Meredith G, Petrella RJ, Santos WL, Filman DJ, Hogle JM, et al. (2008) The human cytomegalovirus UL44 C clamp wraps around DNA. Structure 16: 1214-1225.
9. Appleton BA, Loregian A, Filman DJ, Coen DM, Hogle JM, (2004) The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell 15: 233-244.
10. Gibson W, Murphy TL, Roby C, (1981) Cytomegalovirus-infected cells contain a DNA-binding protein. Virology 111: 251-262.
11. Alvisi G, Jans DA, Guo J, Pinna LA, Ripalti A, (2005) A protein kinase CK2 site flanking the nuclear targeting signal enhances nuclear transport of human cytomegalovirus ppUL44. Traffic 6: 1002-1013.
12. Alvisi G, Marin O, Pari G, Mancini M, Avanzi S, et al. (2011) Multiple phosphorylation sites at the C-terminus regulate nuclear import of HCMV DNA polymerase processivity factor ppUL44. Virology 417: 259-267.
13. Fulcher AJ, Roth DM, Fatima S, Alvisi G, Jans DA, (2010) The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal. FASEB J 24: 1454-1466.
14. Loregian A, Appleton BA, Hogle JM, Coen DM, (2004) Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J Virol 78: 9084-9092.
15. Appleton BA, Brooks J, Loregian A, Filman DJ, Coen DM, et al. (2006) Crystal Structure of the Cytomegalovirus DNA Polymerase Subunit UL44 in Complex with the C Terminus from the Catalytic Subunit: DIFFERENCES IN STRUCTURE AND FUNCTION RELATIVE TO UNLIGANDED UL44. J Biol Chem 281: 5224-5232.
16. Alvisi G, Ripalti A, Ngankeu A, Giannandrea M, Caraffi SG, et al. (2006) Human cytomegalovirus DNA polymerase catalytic subunit pUL54 possesses independently acting nuclear localization and ppUL44 binding motifs. Traffic 7: 1322-1332.
17. Ertl PF, Powell KL, (1992) Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J Virol 66: 4126-4133.
18. Weiland KL, Oien NL, Homa F, Wathen MW, (1994) Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res 34: 191-206.
19. Stinski MF, (1978) Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides. J Virol 26: 686-701.
20. Geballe AP, Leach FS, Mocarski ES, (1986) Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol 57: 864-874.
21. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
22. Wilkinson KA, Henley JM, (2010) Mechanisms, regulation and consequences of protein SUMOylation. J Biochem 428: 133-145.
23. Kamitani T, Kito K, Nguyen HP, Fukuda-Kamitani T, Yeh ET, (1998) Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem 273: 11349-11353.
24. Saitoh H, Hinchey J, (2000) Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275: 6252-6258.
25. Moretti P, Freeman K, Coodly L, Shore D, (1994) Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein RAP1. Genes Dev 8: 2257-2269.
26. Strang BL, Sinigalia E, Silva LA, Coen DM, Loregian A, (2009) Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84. J Virol 83: 7581-7589.
27. Fan Z, Zhuo Y, Tan X, Zhou Z, Yuan J, et al. (2006) SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. J Med Virol 78: 1365-1373.
28. Muratore G, Goracci L, Mercorelli B, Foeglein A, Digard P, et al. (2012) Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc Natl Acad Sci U S A 109: 6247-6252.
29. Loregian A, Appleton BA, Hogle JM, Coen DM, (2004) Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J Virol 78: 158-167.
30. Uchimura Y, Nakamura M, Sugasawa K, Nakao M, Saitoh H, (2004) Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli. Anal Biochem 331: 204-206.
31. Alvisi G, Jans DA, Ripalti A, (2006) Human cytomegalovirus (HCMV) DNA polymerase processivity factor ppUL44 dimerizes in the cytosol before translocation to the nucleus. Biochemistry 45: 6866-6872.
32. Camozzi D, Pignatelli S, Valvo C, Lattanzi G, Capanni C, et al. (2008) Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53. J Gen Virol 89: 731-740.
33. Marschall M, Freitag M, Suchy P, Romaker D, Kupfer R, et al. (2003) The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311: 60-71.
34. Panza E, Marini M, Pecci A, Giacopelli F, Bozzi V, et al. (2008) Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. Pathogenetics 1: 5.
35. Alvisi G, Avanzi S, Musiani D, Camozzi D, Leoni V, et al. (2008) Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal. Biochemistry 47: 13764-13777.
36. Alvisi G, Roth DM, Camozzi D, Pari GS, Loregian A, et al. (2009) The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells. J Virol 83: 9567-9576.
37. Rose MD, Winston R, Hieter P (1990) Methods in yeast genetics: A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
38. Schiestl RH, Gietz RD, (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet 16: 339-346.
39. Breeden L, Nasmyth K, (1985) Regulation of the yeast HO gene. Cold Spring Harb Symp Quant Biol 50: 643-650.
40. Breeden L, Nasmyth K, (1987) Cell cycle control of the yeast HO gene: cis- and trans-acting regulators. Cell 48: 389-397.
41. Ayyagari R, Impellizzeri KJ, Yoder BL, Gary SL, Burgers PM, (1995) A mutational analysis of the yeast proliferating cell nuclear antigen indicates distinct roles in DNA replication and DNA repair. Mol Cell Biol 15: 4420-4429.
42. Swift S, Lorens J, Achacoso P, Nolan GP (2001) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol Chapter 10: Unit 10.17C.
43. Xu Y, Ahn JH, Cheng M, apRhys CM, Chiou CJ, et al. (2001) Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J Virol 75: 10683-10695.
44. Ahn JH, Hayward GS, (2000) Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274: 39-55.
45. Hsiao HH, Meulmeester E, Frank BT, Melchior F, Urlaub H, (2009) "ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol Cell Proteomics 8: 2664-2675.
46. Mengoli C, Cusinato R, Biasolo MA, Cesaro S, Parolin C, et al. (2004) Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J Med Virol 74: 78-84.
47. Loregian A, Coen DM, (2006) Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem Biol 13: 191-200.
48. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, et al. (1993) The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7: 555-569.
49. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP, (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266: 2002-2006.
50. Ahn JH, Xu Y, Jang WJ, Matunis MJ, Hayward GS, (2001) Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J Virol 75: 3859-3872.
51. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD, (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108: 345-356.
52. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18: 6462-6471.
53. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, et al. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
54. Matunis MJ, Coutavas E, Blobel G, (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135: 1457-1470.
55. Lee GW, Melchior F, Matunis MJ, Mahajan R, Tian Q, et al. (1998) Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue. J Biol Chem 273: 6503-6507.
56. Seeler JS, Dejean A, (2003) Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4: 690-699.
57. Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, et al. (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24: 341-354.
58. Tseng CH, Cheng TS, Shu CY, Jeng KS, Lai MM, (2010) Modification of small hepatitis delta virus antigen by SUMO protein. J Virol 84: 918-927.
59. Parker JL, Bucceri A, Davies AA, Heidrich K, Windecker H, et al. (2008) SUMO modification of PCNA is controlled by DNA. EMBO J 27: 2422-2431.
60. Sinigalia E, Alvisi G, Mercorelli B, Coen DM, Pari GS, et al. (2008) Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. J Virol 82: 12574-12579.
61. Penfold ME, Mocarski ES, (1997) Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 239: 46-61.
62. Ahn JH, Jang WJ, Hayward GS, (1999) The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J Virol 73: 10458-10471.
63. Fortunato EA, Spector DH, (1998) p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72: 2033-2039.
64. Albrecht T, Cavallo T, Cole NL, Graves K, (1980) Cytomegalovirus: development and progression of cytopathic effects in human cell culture. Lab Invest 42: 1-7.
65. Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, et al. (2009) Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog 5: e1000275.
66. Xu Y, Colletti KS, Pari GS, (2002) Human cytomegalovirus UL84 localizes to the cell nucleus via a nuclear localization signal and is a component of viral replication compartments. J Virol 76: 8931-8938.
67. Silva LA, Loregian A, Pari GS, Strang BL, Coen DM, (2010) The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication. J Virol 84: 11563-11568.
68. Jeruzalmi D, O'Donnell M, Kuriyan J, (2002) Clamp loaders and sliding clamps. Curr Opin Struct Biol 12: 217-224.
69. Pfander B, Moldovan GL, Sacher M, Hoege C, Jentsch S, (2005) SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 436: 428-433.
70. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F, (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97-107.
71. Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, et al. (2008) Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. J Virol 82: 1638-1646.
72. Isomura H, Stinski MF, Kudoh A, Nakayama S, Iwahori S, et al. (2007) The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis. J Virol 81: 6197-6206.
73. Adamson AL, (2005) Effects of SUMO-1 upon Epstein-Barr virus BZLF1 function and BMRF1 expression. Biochem Biophys Res Commun 336: 22-28.
74. Da Silva M, Upton C, (2009) Vaccinia virus G8R protein: a structural ortholog of proliferating cell nuclear antigen (PCNA). PLoS One 4: e5479.